文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

多平面气道手术对比内科管理对中重度阻塞性睡眠呼吸暂停患者呼吸暂停低通气指数及日间嗜睡的影响:SAMS随机临床试验

Effect of Multilevel Upper Airway Surgery vs Medical Management on the Apnea-Hypopnea Index and Patient-Reported Daytime Sleepiness Among Patients With Moderate or Severe Obstructive Sleep Apnea: The SAMS Randomized Clinical Trial.
PubMed 文献 · JAMA · 2020-01-01
一句话结论对常规器械治疗失败的中重度OSA成人,多平面气道手术较内科管理在6个月时降低AHI和ESS,但为初步研究,需进一步验证。

SAMS多中心、平行组、开放标签随机临床试验纳入102例常规治疗失败的有症状中重度OSA成人,随机分为多平面手术组(改良悬雍垂腭咽成形术联合微创舌体积缩减,n=51)或继续内科管理组(n=51)。6个月时,手术组AHI从基线47.9降至20.8,内科管理组从45.3降至34.5,基线校正组间差为-17.6次/小时(95%CI -26.8至-8.4;P<.001);ESS手术组从12.4降至5.3,内科管理组从11.1降至10.5,组间差-6.7(95%CI -8.2至-5.2;P<.001)。手术组2例(4%)发生严重不良事件。作者认为该初步研究显示手术可减少呼吸暂停低通气事件和患者报告的嗜睡,但需进一步研究确认。

要点

  • 常规器械治疗失败的中重度OSA成人,多平面手术较内科管理6个月时AHI多降低17.6次/小时(95%CI -26.8至-8.4;P<.001)。
  • 同一人群6个月时ESS手术组较内科管理组多降低6.7分(95%CI -8.2至-5.2;P<.001),超过最小临床重要差异2分。
  • 手术组2例(4%)发生严重不良事件:术后第5天心肌梗死1例,因陈旧血性呕吐物住院观察1例。
  • 作者结论为初步研究,需在更多人群中进一步研究以确认临床效用、长期疗效和安全性。

适用人群与场景

  • 有症状的中重度阻塞性睡眠呼吸暂停成人,常规治疗(器械治疗)失败者。
  • 纳入时间为2014年11月至2017年10月,随访至2018年8月。

诊断标准与关键阈值

  • 呼吸暂停低通气指数(AHI)15-30次/小时为中度OSA,>30次/小时为重度OSA。
  • Epworth嗜睡量表(ESS)范围0-24分,>10分提示病理性嗜睡。
  • AHI最小临床重要差异为15次/小时,ESS为2分。

处置流程与药物剂量

  • 多平面手术组(n=51):改良悬雍垂腭咽成形术联合微创舌体积缩减。
  • 内科管理组(n=51):继续内科管理,如睡眠体位建议、减重等。

研究设计与关键结果

  • 多中心、平行组、开放标签随机临床试验,102例随机(平均[SD]年龄44.6[12.8]岁;女性18例[18%]),91例(89%)完成试验。
  • 6个月时AHI:手术组基线47.9降至20.8,内科管理组基线45.3降至34.5,基线校正组间差-17.6次/小时(95%CI -26.8至-8.4;P<.001)。
  • 6个月时ESS:手术组基线12.4降至5.3,内科管理组基线11.1降至10.5,基线校正组间差-6.7(95%CI -8.2至-5.2;P<.001)。
  • 手术组2例(4%)发生严重不良事件:1例术后第5天心肌梗死,1例因陈旧血性呕吐物住院观察。

证据类型、等级与局限

  • 随机临床试验(多中心、平行组、开放标签)。
  • 局限:作者称其为初步研究,需在更多人群中进一步研究以确认发现,并需了解临床效用、长期疗效和安全性。

对床旁实践的改变

  • 对常规器械治疗失败的中重度OSA成人,多平面气道手术在6个月时降低AHI和ESS,但作者认为需进一步研究确认临床效用、长期疗效和安全性。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Many adults with obstructive sleep apnea (OSA) use device treatments inadequately and remain untreated.

OBJECTIVE: To determine whether combined palatal and tongue surgery to enlarge or stabilize the upper airway is an effective treatment for patients with OSA when conventional device treatment failed.

DESIGN, SETTING, AND PARTICIPANTS: Multicenter, parallel-group, open-label randomized clinical trial of upper airway surgery vs ongoing medical management. Adults with symptomatic moderate or severe OSA in whom conventional treatments had failed were enrolled between November 2014 and October 2017, with follow-up until August 2018.

INTERVENTIONS: Multilevel surgery (modified uvulopalatopharyngoplasty and minimally invasive tongue volume reduction; n = 51) or ongoing medical management (eg, advice on sleep positioning, weight loss; n = 51).

MAIN OUTCOMES AND MEASURES: Primary outcome measures were the apnea-hypopnea index (AHI; ie, the number of apnea and hypopnea events/h; 15-30 indicates moderate and >30 indicates severe OSA) and the Epworth Sleepiness Scale (ESS; range, 0-24; >10 indicates pathological sleepiness). Baseline-adjusted differences between groups at 6 months were assessed. Minimal clinically important differences are 15 events per hour for AHI and 2 units for ESS.

RESULTS: Among 102 participants who were randomized (mean [SD] age, 44.6 [12.8] years; 18 [18%] women), 91 (89%) completed the trial. The mean AHI was 47.9 at baseline and 20.8 at 6 months for the surgery group and 45.3 at baseline and 34.5 at 6 months for the medical management group (mean baseline-adjusted between-group difference at 6 mo, -17.6 events/h [95% CI, -26.8 to -8.4]; P < .001). The mean ESS was 12.4 at baseline and 5.3 at 6 months in the surgery group and 11.1 at baseline and 10.5 at 6 months in the medical management group (mean baseline-adjusted between-group difference at 6 mo, -6.7 [95% CI, -8.2 to -5.2]; P < .001). Two participants (4%) in the surgery group had serious adverse events (1 had a myocardial infarction on postoperative day 5 and 1 was hospitalized for observation following hematemesis of old blood).

CONCLUSIONS AND RELEVANCE: In this preliminary study of adults with moderate or severe OSA in whom conventional therapy had failed, combined palatal and tongue surgery, compared with medical management, reduced the number of apnea and hypopnea events and patient-reported sleepiness at 6 months. Further research is needed to confirm these findings in additional populations and to understand clinical utility, long-term efficacy, and safety of multilevel upper airway surgery for treatment of patients with OSA.

TRIAL REGISTRATION: Australian New Zealand Clinical Trials Registry: ACTRN12614000338662.

来源:JAMA,查看原文。版权归原作者所有。

参考来源

  1. MacKay S, Carney AS, Catcheside PG, et al. Effect of Multilevel Upper Airway Surgery vs Medical Management on the Apnea-Hypopnea Index and Patient-Reported Daytime Sleepiness Among Patients With Moderate or Severe Obstructive Sleep Apnea: The SAMS Randomized Clinical Trial. JAMA. 2020. PMID: 32886102. doi:10.1001/jama.2020.14265

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。